Why is Invivyd, Inc. ?
- The company has declared positive results for the last 2 consecutive quarters
- NET SALES(Q) At USD 11.79 MM has Grown at 420.58%
- OPERATING CASH FLOW(Y) Highest at USD -113.11 MM
- RAW MATERIAL COST(Y) Fallen by -22.8% (YoY)
- The stock has generated a return of 435.26% in the last 1 year, much higher than market (S&P 500) returns of 16.49%
How much should you buy?
- Overall Portfolio exposure to Invivyd, Inc. should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Invivyd, Inc. for you?
High Risk, High Return
Quality key factors
Valuation Key Factors 
Technical key factors
Technical Movement
At USD 11.79 MM has Grown at 420.58%
Highest at USD -113.11 MM
Fallen by -22.8% (YoY
Highest at 2.21 times
Highest at 7.49 times
Highest at USD -14.56 MM
Highest at -123.51 %
Highest at USD -14.66 MM
Highest at USD -14.66 MM
Highest at USD -0.12
Highest at -74.65 %
Here's what is working for Invivyd, Inc.
Net Sales (USD MM)
Operating Cash Flows (USD MM)
Operating Profit (USD MM)
Operating Profit to Sales
Pre-Tax Profit (USD MM)
Pre-Tax Profit (USD MM)
Net Profit (USD MM)
Net Profit (USD MM)
EPS (USD)
Inventory Turnover Ratio
Debtors Turnover Ratio
Raw Material Cost as a percentage of Sales
Here's what is not working for Invivyd, Inc.
Debt-Equity Ratio






